Cutting-Edge Research on Antiviral Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 30 July 2024 | Viewed by 1076
Special Issue Editors
Interests: sustainability and neglected diseases; analytics; food chemistry; medicinal chemistry; rare tumors and emerging viruses
Special Issues, Collections and Topics in MDPI journals
Interests: antiviral compounds; novel foods; edible insects; nutraceuticals and functionalized foods
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the last ten years, globalization, global warming, and population aging have contributed to the spread of emerging or re-emerging viruses such as SARS-CoV-2, West Nile, Dengue, Zika, Ebola, and, recently, the monkeypox virus. The number of reported cases is impressive, and considering that many viral infections occur asymptomatically, it is conceivable that numbers will increase significantly in the coming years.
With the risk of new epidemics just around the corner, there is an urgent need to find new antivirals that are able to counter future epidemics. Antivirals can be designed using computational methods, rational drug design, high-throughput screening, or by finding novel uses for already-developed compounds (drug repurposing).
This Special Issue of IJMS will focus on advances in the field of antiviral therapy, including the development of novel antivirals, drug-repurposing approaches, mechanism of action elucidation, sustainable procedures to scale up the synthesis of existing antivirals, and optimization of ADME and PK properties. We welcome the submission of papers focusing on the development of antivirals using cutting-edge technologies such as proteolysis-targeting chimeras (PROTACs) and ribonuclease-targeting chimeras (RIBOTACs).
Dr. Elena Dreassi
Dr. Annalaura Brai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antivirals
- PROTACs
- RIBOTACs
- ADME
- PK
- medicinal chemistry
- viruses
